AChR α 7 Antibodies

Santa Cruz Biotechnology delivers a wide array of AChR α 7 monoclonal antibodies for neuroscience and cellular signaling research. AChR α 7 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The α 7 nicotinic acetylcholine receptor (AChR) plays a critical role in neurotransmission and is involved in cognitive functions such as learning and memory. Dysregulation of AChR α 7 has been implicated in several neurological disorders, including Alzheimer's disease and schizophrenia, making it a significant target for therapeutic research. Understanding the function and modulation of AChR α 7 is essential for developing potential treatments for neurological conditions. Research focusing on AChR α 7 continues to reveal new insights into neural pathways and potential therapeutic approaches. Investigating AChR α 7 expression patterns helps identify specific cellular responses in various physiological states. Exploring AChR α 7 signaling mechanisms provides valuable information about neurotransmitter regulation and synaptic plasticity. Santa Cruz Biotechnology monoclonal antibodies for AChR α 7 support researchers worldwide in advancing our understanding of neurological health and disease mechanisms.